Premium

Something unusual is happening behind the scenes at Alpha Cognition

A biotech fund is increasing its holdings in an Alzheimer's drug company showing strong sales growth and high gross profitability.

By the SpyStocks desk · Oct 28, 2026, 05:17 · 1h ago · 4 min read

The rest of this story is for members

The rest is for members

The story continues: the full timeline, the transaction ranges, and the names the forms carry.

Premium comes through the Telegram channel. Already have a code? Sign in to activate it.

Good intel travels.

Share this story